Obesity and Overweight: Causes, Health Effects and What Treatment Really Looks Like

What obesity is

Obesity is a chronic condition of excess body fat that impairs health. The screening measure is body mass index — weight (kg) divided by height (m) squared:

(Thresholds are lower in some Asian populations — risk rises from BMI ~23 — and BMI misreads muscular and older bodies; see the FAQ.) Where fat sits matters as much as how much: visceral fat around the organs, signalled by waist size, drives most of the metabolic harm via insulin resistance.

Roughly 40% of US adults and a quarter of UK and Australian adults live with obesity; rates have tripled globally since the 1970s — a speed only environment, not genes, can explain, acting on genetic susceptibility that varies person to person.

Why weight rises — and defends itself

The arithmetic (energy in exceeding energy out) is true and radically incomplete. What sets the terms of that arithmetic:

• Genetics — heritability of weight rivals height; hundreds of gene variants tune appetite, satiety and fat storage
• The food environment — cheap, engineered, energy-dense, portion-inflated, everywhere
• Appetite biology — hunger and fullness are hormonal (ghrelin, leptin, GLP-1, PYY), and these systems vary between people and shift against you after weight loss
• Sleep loss and shift work — short sleep raises hunger hormones and intake within days
• Stress — cortisol drives appetite and abdominal storage (see stress and blood sugar)
• Medications — some antidepressants, antipsychotics, steroids, insulin and sulfonylureas, beta-blockers
• Life stages and conditions — pregnancy, menopause, quitting smoking, hypothyroidism, PCOS
• Alcohol — calorie-dense and disinhibiting

After loss, the body mounts a defense — hunger up, expenditure down, persisting for years — which reframes regain as physiology to be managed, not failure to be judged.

Health effects

Excess fat, especially visceral, is metabolically active tissue driving inflammation and insulin resistance. Downstream, obesity raises the risk of: type 2 diabetes (the strongest link — most cases are weight-attributable), high blood pressure, heart disease and stroke, metabolic syndrome, fatty liver disease, sleep apnea, several cancers (bowel, breast after menopause, uterine, kidney among them), osteoarthritis of knees and hips, gallstones, gout, infertility and pregnancy complications, depression — amplified by stigma — and reduced life expectancy at higher classes.

The clinical flip side: 5–10% loss improves nearly every item on that list measurably — the Diabetes Prevention Program's 58% diabetes-risk reduction came from ~7% loss — which is why treatment targets health-relevant percentages, not ideal weights.

Assessment

Beyond BMI and waist: blood pressure, A1C or fasting glucose, lipids, liver enzymes, thyroid where suspected, sleep-apnea screening, medication review, and the history that finds contributors — weight trajectory, eating pattern, sleep, mood, prior attempts. Rapid unexplained gain has its own cause list worth ruling through.

Treatment: the ladder

Foundation — structured lifestyle change. A moderate calorie deficit built on protein and fiber (see protein and weight loss and fibre); any dietary pattern the person can keep — Mediterranean, lower-carb, low-fat — since adherence, not brand, predicts results; 150+ minutes weekly activity plus resistance training to protect muscle; sleep and stress addressed as levers rather than afterthoughts; and ideally a structured program with follow-up, which doubles results versus advice alone. Expected: 5–8% at one year, with the safe-rate arithmetic here.

Medications — for BMI 30+, or 27+ with weight-related conditions, alongside lifestyle. The GLP-1 receptor agonists (semaglutide) and dual agonists (tirzepatide) produce average losses of roughly 15% and 20% respectively in trials — territory formerly reserved for surgery — by quieting appetite signalling; side effects are mainly gastrointestinal, cost and access are real barriers, and stopping usually brings regain, so they are treated as chronic therapy. Older options (orlistat, phentermine combinations, naltrexone-bupropion) produce 3–9% with different trade-offs.

Bariatric surgery — for BMI 40+, or 35+ with conditions: sleeve gastrectomy or gastric bypass produce 25–30% durable loss, high rates of diabetes remission, and reduced mortality in long-term studies. Serious surgery with lifelong follow-up and supplementation, and the most effective treatment that exists.

What has no place: crash diets that strip muscle and rebound, "detoxes", and the fat-burner aisle — dissected honestly in Do fat burners work?

When to see a doctor

Worth a visit: BMI 30+ (or 27+ with any weight-linked condition), a rising waist despite effort, unexplained gain, snoring with daytime sleepiness, or simply wanting a structured plan — treatment has improved enough that asking is no longer a formality. Seek prompt care for rapid gain with swelling or breathlessness (fluid, not fat — heart or kidney territory).

Frequently asked questions

References